Clinical Trials

Showing trials with last updates posted in 2014.

NCT00112905 | TERMINATED | PHASE2
27 participants

Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium

Study Type:
INTERVENTIONAL
Last Updated:
2014-05-30
Start Date:
2005-10-31
Completion:
2008-03-31
Conditions
  • Adenocarcinoma of the Bladder
  • Distal Urethral Cancer
  • Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter
  • Proximal Urethral Cancer
  • Recurrent Bladder Cancer
  • Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter
  • Recurrent Urethral Cancer
  • Regional Transitional Cell Cancer of the Renal Pelvis and Ureter
  • Squamous Cell Carcinoma of the Bladder
  • Stage III Bladder Cancer
  • Stage IV Bladder Cancer
  • Transitional Cell Carcinoma of the Bladder
  • Urethral Cancer Associated With Invasive Bladder Cancer
Interventions
  • DRUG
  • OTHER
NCT00089076 | TERMINATED | PHASE1/PHASE2
18 participants

MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2014-05-30
Start Date:
2004-06-30
Completion:
2008-07-31
Conditions
  • Adult Grade III Lymphomatoid Granulomatosis
  • B-cell Chronic Lymphocytic Leukemia
  • Cutaneous B-cell Non-Hodgkin Lymphoma
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • Intraocular Lymphoma
  • Nodal Marginal Zone B-cell Lymphoma
  • Recurrent Adult Burkitt Lymphoma
  • Recurrent Adult Diffuse Large Cell Lymphoma
  • Recurrent Adult Diffuse Mixed Cell Lymphoma
  • Recurrent Adult Diffuse Small Cleaved Cell Lymphoma
  • Recurrent Adult Grade III Lymphomatoid Granulomatosis
  • Recurrent Adult Hodgkin Lymphoma
  • Recurrent Adult Immunoblastic Large Cell Lymphoma
  • Recurrent Adult Lymphoblastic Lymphoma
  • Recurrent Grade 1 Follicular Lymphoma
  • Recurrent Grade 2 Follicular Lymphoma
  • Recurrent Mantle Cell Lymphoma
  • Recurrent Marginal Zone Lymphoma
  • Refractory Hairy Cell Leukemia
  • Small Intestine Lymphoma
  • Splenic Marginal Zone Lymphoma
  • Testicular Lymphoma
  • Waldenström Macroglobulinemia
Interventions
  • BIOLOGICAL
  • OTHER
NCT02149758 | COMPLETED | PHASE4
40 participants

EFFECT OF SELECTIVE COX-2 INHIBITOR (ETORICOXIB) ALONG WITH SCALING AND ROOT PLANING (SRP) ON CLINICAL PARAMETERS AND SALIVARY LEVEL OF SUPEROXIDE DISMUTASE IN CHRONIC GENERALIZED PERIODONTITIS A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOUBLE-MASKED RANDOMIZED CONTROLLED TRIAL (RCT).

Study Type:
INTERVENTIONAL
Last Updated:
2014-05-29
Start Date:
2013-01-31
Completion:
2013-06-30
Conditions
  • Cyclooxygenase Two Inhibitors
  • Etoricoxib
  • Periodontitis
  • Superoxide Dismutase
  • Saliva
Interventions
  • DRUG
No Results Yet
NCT02149641 | COMPLETED
42 participants

Parotid-sparing IMRT for Nasopharyngeal Cancer

Study Type:
OBSERVATIONAL
Last Updated:
2014-05-29
Start Date:
2006-02-28
Completion:
2011-04-30
Conditions
  • Nasopharyngeal Cancers
  • Intensity Modulated Radiotherapy With Chemotherapy
Interventions
  • RADIATION
No Results Yet
NCT02148978 | UNKNOWN | NA
30 participants

Cystic Fibrosis Related Diabetes

Study Type:
INTERVENTIONAL
Last Updated:
2014-05-29
Start Date:
2014-03-31
Completion:
2015-08-31
Conditions
  • Cystic Fibrosis
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page